Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised, Open-label, Active-controlled Trial of the Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France

NCT00955162 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT00955162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised, Open-label, Active-controlled Trial of the Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France
Lead sponsor
Indivior Inc.
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2009
Completion date
May 31, 2011
Enrollment
270 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependency